P4_2 How to fly your dragon

In this paper we calculate the minimum area and length of a dragon’s wing for it to be able to fly. The minimum area was calculated to be 224m^2 and the length was 35.6m

P4_5 Atmospheric ODSTs

In this paper the maximum acceleration on the ODST and the pod was found to be $-4g$, with a braking thrusters force of $14100$ N during the last $50$ m of descent. This deceleration brings the impact velocity of the pod to below velocity of $1$ ms$^{-1}$, should the braking thrusters fail to fire the pod will hit the ground with a velocity of $43.2$ ms$^{-1}$ killing the trooper

P4_4 Snorlax used Body Slam

In this paper we consider the maximum strength of Ash's Snorlax, from the Pokemon original TV series, this will occur when the Snorlax jumps as high as it can. The maximum height of the jump was calculated to be 41.8 m, the velocity it impacts the ground with is 28.1 ms^-1 and the momentum of the Snorlax when it hits the ground is 12,900 kgms^-1

P4_3 Light Ordnance

In this paper we consider a weapon system that fires a laser at an interplanetary vessel. We calculate the energy required to melt through a vessel’s armoured hull, of thickness 0.254 m, from a shot from a laser with a calibre of 16 inches. The energy required is found to be E = 34449 J. Using this energy, the recoil of the laser firing was calculated to be ρ = 1.15x10−4 kgms−1

P4_6 Wind swept

This paper discusses the plausibility of the thruster in the Iron Man suit being used as weapons to push a human back. It was determined that the shock-wave produced by the change in temperature due to the thrusters would produce a force of $183$ kN on a person it was shot at, this would cause the person to accelerate at $2614$ ms$^{-2}$ killing the person

RESTORE: an exploratory trial of an online intervention to enhance self-efficacy to manage problems associated with cancer-related fatigue following primary cancer treatment: study protocol for a randomized controlled trial

Background: There are over 25 million people worldwide living with or beyond cancer and this number is increasing. Cancer survivors face a range of problems following primary treatment. One of the most frequently reported and distressing symptoms experienced by cancer survivors is fatigue. There is growing support for survivors who are experiencing problems after cancer treatment to engage in supported self-management. To date there is some evidence of effective interventions to manage fatigue in this population; however, to our knowledge there are no online resources that draw on this information to support self-management of fatigue. This paper describes the protocol for an exploratory randomized controlled trial of an online intervention to support self-management of cancer-related fatigue after primary cancer treatment.Methods/design: This is a parallel-group two-armed (1:1) exploratory randomized controlled trial including 125 cancer survivors experiencing fatigue (scoring ≥4 on a unidimensional 11-point numeric rating scale for fatigue intensity) within five years of primary treatment completion with curative intent. Participants will be recruited from 13 NHS Trusts across the UK and randomized to either the online intervention (RESTORE), or a leaflet comparator (Macmillan Cancer Backup, Coping with Fatigue). The primary outcome is a change in Perceived Self-Efficacy for Fatigue Self-Management (as measured by the Perceived Self-Efficacy for Fatigue Self-Management Instrument). Secondary outcomes include impact on perception and experience of fatigue (measured by the Brief Fatigue Inventory), and quality of life (measured by the Functional Assessment of Cancer Therapy - General and the Personal Wellbeing Index). Outcome measures will be collected at baseline, 6 weeks (completion of intervention), and 3 months. Process evaluation (including telephone interviews with recruiting staff and participants) will determine acceptability of the intervention and trial processes.Discussion: Data from this trial will be used to refine the intervention and contribute to the design of an effectiveness trial. This intervention will be expanded to address other cancer-related problems important to cancer survivors following primary cancer treatment

Experiences of men with breast cancer: an exploratory focus group study

Management and care of men with breast cancer is based on that developed for women. Our study reports that men have specific issues regarding certain aspects of their breast cancer experience, including diagnosis, disclosure, support and gender-specific information, and offers suggestions for improved patient care

Cancer survivors’ self-efficacy to self-manage in the year following primary treatment

PURPOSECancer survivors are increasingly expected to manage the consequences of cancer and its treatment for themselves. There is evidence that self-efficacy is important for successful self-management and that this can be enhanced with support. The purpose of this study was to assess self-efficacy to manage problems in the year following primary treatment.METHODSThis cross-sectional online survey included cancer survivors who had completed their treatment within the past 12 months. Self-efficacy was assessed and variables expected to be associated with self-efficacy were measured using validated scales including quality of life, well-being, illness perceptions, depression and social support.RESULTSOne hundred eighty-two respondents (mean age 50; 81 % female) completed the survey. They had been treated for a range of cancers; most commonly breast (45 %). Self-efficacy scores varied between individuals and according to the illness-related task to be managed. Respondents were least confident in managing fatigue and most confident in accessing information about their cancer. Individuals most likely to report low self-efficacy were women, those experiencing higher levels of pain and/or depression, lower well-being scores, lower socio-economic status, low levels of social support, or a more negative perception of cancer.CONCLUSIONSSelf-efficacy to self-manage problems faced as a consequence of cancer and its treatment can vary widely in the year following treatment. Fatigue may be particularly difficult to manage.IMPLICATIONS FOR CANCER SURVIVORSVariations in self-efficacy highlight the importance of assessing specific problems faced and people's confidence to manage them in order to tailor appropriate self-management support